The development of clinical type and personalized therapy for asthma: from bench to bed
Zhihong Chen1,Xiaoqiong Su2,Xiangdong Wang2
1.Respiratory Division of Zhongshan Hospital, Fudan University, Shanghai 200032,China 2. Biomedical Research Center of Zhongshan Hospital, Fudan University,Shanghai 200032,China
The development of clinical type and personalized therapy for asthma: from bench to bed
摘要:With deep understanding of pathogenesis in asthma, this disorder with vast heterogeneity should be redefined by clinical, pathologic and molecular biological characteristics.As the target therapy has succeeded in specific subgroup of asthmatics according to “endotype” theory, “one size fits all” approach is facing major challenges.It implies traditional non specific asthma treatment such as corticosteroid, theophylline will turn to target therapy dominated specific treatment such as anti IgE, anti IL-5 antibody et al.These new therapies will open a brand new field for asthma treatment.
出版日期: 2015-04-22
引用本文:
Zhihong Chen,Xiaoqiong Su,Xiangdong Wang. The development of clinical type and personalized therapy for asthma: from bench to bed[J]. 转化医学研究, 2014, 4(4): 104-104.
